Fidia Boosts Share Capital After Major Bond-to-Equity Conversion

Fidia Spa ( (IT:FDA) ) has provided an update.

Fidia has announced a significant change in its share capital following the conversion of a tranche of its previously approved convertible bond loan into ordinary shares. The operation, executed through multiple conversions in April 2026, reflects the progressive transformation of bondholder claims into equity.

As a result, the company’s fully paid-in share capital has risen by €440,000 to €11,357,761.90, with the number of ordinary shares increasing from 66,542,927 to 113,745,306, all admitted to trading on Euronext Milan under ISIN IT0005654683. The updated capital structure has been formally registered, signalling a strengthened equity base and potential dilution for existing shareholders but improved financial flexibility for the group.

The formal filing of the updated Articles of Association and certification of the capital increase with the Turin Companies’ Register confirms completion of this phase of Fidia’s recapitalization path. For investors, the move underlines management’s use of convertible instruments to support growth while aligning the company’s capital structure with its strategic ambitions in advanced milling technologies.

More about Fidia Spa

Fidia S.p.A., headquartered in San Mauro Torinese and listed on Euronext Milan, is a global leader in high-performance integrated milling systems. The group, with over 50 years of experience and around 135 employees, serves mainly the automotive mold and aerospace sectors with numerical controls, high-speed milling machines, and CAM software for complex shapes.

Average Trading Volume: 3,211,415

Technical Sentiment Signal: Strong Sell

Current Market Cap: €532.3K

See more data about FDA stock on TipRanks’ Stock Analysis page.